| |
|
Waiting times, revascularization modality, and outcomes after acute myocardial infarction at hospitals with and without on-site revascularization facilities in Canada. |
| |
|
A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. |
| |
|
Danish multicenter randomized study on fibrinolytic therapy versus acute coronary angioplasty in acute myocardial infarction: rationale and design of the DANish trial in Acute Myocardial Infarction-2 (DANAMI-2). |
| |
|
Comparison of impact of emergency percutaneous revascularization on outcome of patients > or =75 to those < 75 years of age with acute myocardial infarction complicated by cardiogenic shock. |
| |
|
A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction*1. |
| |
|
ST segment resolution in ASSENT 3: insights into the role of three different treatment strategies for acute myocardial infarction. |
| |
|
Outcomes following Bail-Out abciximab administration during primary intervention in acute myocardial infarction (The CADILLAC Trial). |
| |
|
Outcomes of bail-out stenting for suboptimal balloon angioplasty during primary intervention in acute myocardial infarction (The CADILLAC trial). |
| |
|
Cost-Effectiveness of Coronary Stenting and Abciximab for Patients With Acute Myocardial Infarction: Results From the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) Trial. |
| |
|
Relation of Thrombolysis in Myocardial Infarction (TIMI) frame count to coronary flow parameters. |
| |
|
Early reperfusion and late clinical outcomes in patients presenting with acute myocardial infarction randomly assigned to primary percutaneous coronary intervention or streptokinase. |
| |
|
Angiographic findings, time course of regional and global left ventricular function, and clinical outcome in diabetic patients with acute myocardial infarction treated with primary percutaneous transluminal coronary angioplasty. |
| |
|
Reflex cardiac activity in ischemia and reperfusion: heart rate turbulence in patients undergoing direct percutaneous coronary intervention for acute myocardial infarction. |
| |
|
Temporal repolarization inhomogeneity and reperfusion arrhythmias in patients undergoing successful primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: impact of admission troponin T. |
| |
|
Impact of Infarct-Related Artery Flow on QT Dynamicity in Patients Undergoing Direct Percutaneous Coronary Intervention for Acute Myocardial Infarction. |
| |
|
Determinants of treatment strategies and survival in acute myocardial infarction: a population-based study in the Florence district, Italy: results of the acute myocardial infarction Florence registry (AMI-Florence). |
| |
|
Acute release of plasminogen activator inhibitor-1 in ST-segment elevation myocardial infarction predicts mortality. |
| |
|
Outcomes of optimal or "stent-like"balloon angioplasty in acutemyocardial infarction: the CADILLAC trial. |
| |
|
Effect of tirofiban before primary angioplasty on initial coronary flow and early ST-segment resolution in patients with acute myocardial infarction. |
| |
|
Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: a meta-analysis. |
| |
|
Synergistic treatment of ST-segment elevation myocardial infarction with pharmacoinvasive recanalization. |
| |
|
Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty. |
| |
|
Outcome in patients treated with primary angioplasty for acute myocardial infarction due to left main coronary artery occlusion. |
| |
|
Thrombolysis in myocardial infarction myocardial perfusion grade in angiography correlates with myocardial salvage in patients with acute myocardial infarction treated with stenting or thrombolysis. |
| |
|
Outcome of urgent and elective percutaneous coronary interventions after pharmacologic reperfusion with tenecteplase combined with unfractionated heparin, enoxaparin, or abciximab. |
| |
|
Facilitated percutaneous coronary intervention in patients with acute myocardial infarction transferred from remote hospitals. |
| |
|
Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry. |
| |
|
Incomplete resolution of ST-segment elevation is a marker of transient microcirculatory dysfunction after stenting for acute myocardial infarction. |
| |
|
Temporal evolution and functional outcome of no reflow: sustained and spontaneously reversible patterns following successful coronary recanalisation. |
| |
|
Impact of microvascular integrity and local viability on left ventricular remodelling after reperfused acute myocardial infarction. |
| |
|
Primary angioplasty with routine stenting compared with thrombolytic therapy in elderly patients with acute myocardial infarction. |
| |
|
Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: six-month follow up and analysis of individual patient data from randomized trials. |
| |
|
International differences in in-hospital revascularization and outcomes following acute myocardial infarction: a multilevel analysis of patients in ASSENT-2. |
| |
|
Preprocedural white blood cell count and death after percutaneous coronary intervention. |
| |
|
Prediction of clinical outcome after mechanical revascularization in acute myocardial infarction by markers of myocardial reperfusion. |
| |
|
Frequency, determinants, and clinical implications of residual intracoronary thrombus following primary angioplasty for acute myocardial infarction. |
| |
|
Comparison of outcomes of diabetic and nondiabetic patients undergoing primary angioplasty for acute myocardial infarction. |
| |
|
Effects of prior beta-blocker therapy on clinical outcomes after primary coronary angioplasty for acute myocardial infarction. |
| |
|
Impact of acute myocardial infarct location on myocardial salvage after stenting or thrombolysis (results from the STOPAMI 1 and 2 trials): Stent versus Thrombolysis for Occluded coronary arteries in Patients with Acute Myocardial Infarction. |
| |
|
Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy. |
| |
|
Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade. |
| |
|
Outcome of primary angioplasty for acute myocardial infarction during routine duty hours versus during off-hours. |
| |
|
Comparison of treatment and outcomes for patients with acute myocardial infarction in Minneapolis/St. Paul, Minnesota, and Goteborg, Sweden. |
| |
|
Relation of coronary flow pattern to myocardial blush grade in patients with first acute myocardial infarction. |
| |
|
Usefulness of myocardial blush grade early and late after primary coronary angioplasty for acute myocardial infarction in predicting left ventricular function. |
| |
|
Evaluation of the percusurge guardwire plus temporary occlusion and aspiration system during primary angioplasty in acute myocardial infarction. |
| |
|
Effect of prodromal angina pectoris on altering the relation between time to reperfusion and outcomes after a first anterior wall acute myocardial infarction. |
| |
|
Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. |
| |
|
Relation of mortality of primary angioplasty during acute myocardial infarction to door-to-Thrombolysis In Myocardial Infarction (TIMI) time. |
| |
|
"Mirror-lake" serial relationship of electrocardiographic and biochemical indices for the detection of reperfusion and the prediction of salvage in patients with acute myocardial infarction. |
| |
|
Evaluation of the association of proximal coronary culprit artery lesion location with clinical outcomes in acute myocardial infarction. |
| |
|
The incidence, predictors, and outcomes of early reinfarction after primary angioplasty for acute myocardial infarction. |
| |
|
Effects of preinfarction angina pectoris on infarct size and in-hospital mortality after coronary intervention for acute myocardial infarction. |
| |
|
Abortion of acute ST segment elevation myocardial infarction after reperfusion: incidence, patients' characteristics, and prognosis. |
| |
|
Quantitative regional wall motion analysis with early contrast ventriculography for the assessment of myocardium at risk in acute myocardial infarction. |
| |
|
Adjunctive platelet glycoprotein IIb/IIIa receptor inhibition with tirofiban before primary angioplasty improves angiographic outcomes: results of the TIrofiban Given in the Emergency Room before Primary Angioplasty (TIGER-PA) pilot trial. |
| |
|
Prognostic significance of transient no-reflow during primary percutaneous coronary intervention for ST-elevation acute myocardial infarction. |
| |
|
Leukocytosis and adverse hospital outcomes after acute myocardial infarction. |
| |
|
Prognostic importance of systolic and diastolic function after acute myocardial infarction. |
| |
|
Stenting and glycoprotein IIb/IIIa inhibition in patients with acute myocardial infarction undergoing percutaneous coronary intervention: Findings from the global registry of acute coronary events (GRACE). |
| |
|
Effect of successful late reperfusion by primary coronary angioplasty on mechanical complications of acute myocardial infarction. |
| |
|
Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything? |
| |
|
ST-segment resolution and late (6-month) left ventricular remodeling after acute myocardial infarction. |
| |
|
Distal protection in native coronary arteries during primary angioplasty in acute myocardial infarction: single-center experience. |
| |
|
Relation of admission white blood cell count to long-term outcomes after primary coronary angioplasty for acute myocardial infarction (The Stent PAMI Trial). |
| |
|
Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction (PRAGUE-2 trial). |
| |
|
Effects of abciximab on microvascular integrity and left ventricular functional recovery in patients with acute infarction treated by primary coronary angioplasty. |
| |
|
Outcomes of primary coronary angioplasty and angioplasty after initial thrombolysis in the treatment of 374 consecutive patients with acute myocardial infarction. |
| |
|
No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention. |
| |
|
Clinical and angiographic characteristics of patients with combined anterior and inferior ST-segment elevation on the initial electrocardiogram during acute myocardial infarction. |
| |
|
Comparative study on transradial approach vs. transfemoral approach in primary stent implantation for patients with acute myocardial infarction: results of the test for myocardial infarction by prospective unicenter randomization for access sites (TEMPURA) trial. |
| |
|
Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction. |
| |
|
Therapy-dependent influence of time-to-treatment interval on myocardial salvage in patients with acute myocardial infarction treated with coronary artery stenting or thrombolysis. |
| |
|
Imbalance between tissue inhibitor of metalloproteinase-4 and matrix metalloproteinases during acute myocardial [correction of myoctardial] ischemia-reperfusion injury. |
| |
|
Effect of monitoring of physician performance on door-to-balloon time for primary angioplasty in acute myocardial infarction. |
| |
|
Challenges and opportunities in quantifying the quality of care for acute myocardial infarction: summary from the Acute Myocardial Infarction Working Group of the American Heart Association/American College of Cardiology First Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke. |
| |
|
Impact of Time to Treatment on Mortality After Prehospital Fibrinolysis or Primary Angioplasty: Data From the CAPTIM Randomized Clinical Trial. |
| |
|
Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction: the benchmark registry. |
| |
|
Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. |
| |
|
Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial. |
| |
|
Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial. |
| |
|
Using eptifibatide in patients undergoing coronary angioplasty with acute myocardial infarction. |
| |
|
Randomized comparison of percutaneous transluminal coronary angioplasty and medical therapy in stable survivors of acute myocardial infarction with single vessel disease: a study of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte. |
| |
|
Primary percutaneous transluminal coronary angioplasty accelerates early myocardial reperfusion compared to thrombolytic therapy in patients with acute myocardial infarction. |
| |
|
Comparison of the radial and the femoral approaches in percutaneous coronary intervention for acute myocardial infarction. |
| |
|
Benefits of direct angioplasty for women and men with acute myocardial infarction: results of the Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes Angioplasty (GUSTO II-B) Angioplasty Substudy. |
| |
| |
 |
